2021
Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
Varma T, Wallach JD, Miller JE, Schnabel D, Skydel JJ, Zhang AD, Dinan MA, Ross JS, Gross CP. Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics. JAMA Network Open 2021, 4: e217063. PMID: 33877309, PMCID: PMC8058642, DOI: 10.1001/jamanetworkopen.2021.7063.Peer-Reviewed Original ResearchConceptsNovel cancer therapeuticsPostmarketing studyBlack patientsCancer therapeuticsDemographic dataOlder adultsUS cancer populationUS Cancer StatisticsCross-sectional studyRace/ethnicityParticipants' demographic characteristicsPercentage of trialsPatient sexCancer populationClinical studiesCancer statisticsMAIN OUTCOMEDrug AdministrationFDA approvalStudy participantsCancer typesDemographic characteristicsDemographic informationStudy samplePatients
2011
Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials
Dinan MA, Compton KL, Dhillon JK, Hammill BG, DeWitt EM, Weinfurt KP, Schulman KA. Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Medical Care 2011, 49: 415-419. PMID: 21368680, PMCID: PMC3682647, DOI: 10.1097/mlr.0b013e3182064aa2.Peer-Reviewed Original ResearchConceptsPatient-reported outcomesClinical trialsPRO instrumentsDisease-specific patient-reported outcomesDisease-specific PRO instrumentsMore PROsUse of PROsPrimary trial outcomeCurrent clinical trialsStudy inclusion criteriaUse of patientMultivariable analysisLarge trialsMajor therapeutic areasInclusion criteriaPRO measurementRelevant outcomesTrial outcomesLogistic regressionClinical researchStudy outcomesPRO outcomesTrialsTherapeutic areasStatistical significance
2008
Effects of Disclosing Financial Interests on Attitudes Toward Clinical Research
Weinfurt KP, Hall MA, Dinan MA, DePuy V, Friedman JY, Allsbrook JS, Sugarman J. Effects of Disclosing Financial Interests on Attitudes Toward Clinical Research. Journal Of General Internal Medicine 2008, 23: 860-866. PMID: 18386101, PMCID: PMC2517900, DOI: 10.1007/s11606-008-0590-4.Peer-Reviewed Original Research
2007
Developing model language for disclosing financial interests to potential clinical research participants.
Weinfurt KP, Allsbrook JS, Friedman JY, Dinan MA, Hall MA, Schulman KA, Sugarman J. Developing model language for disclosing financial interests to potential clinical research participants. Ethics & Human Research 2007, 29: 1-5. PMID: 17364012, PMCID: PMC1825040.Peer-Reviewed Original Research
2006
Views of Potential Research Participants on Financial Conflicts of Interest: Barriers and Opportunities for Effective Disclosure
Weinfurt KP, Friedman JY, Allsbrook JS, Dinan MA, Hall MA, Sugarman J. Views of Potential Research Participants on Financial Conflicts of Interest: Barriers and Opportunities for Effective Disclosure. Journal Of General Internal Medicine 2006, 21: 901-906. PMID: 16918732, PMCID: PMC1831594, DOI: 10.1111/j.1525-1497.2006.00502.x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultDisclosureFocus GroupsHumansMiddle AgedQualitative ResearchResearch SubjectsResearch Support as TopicConceptsGroup of adultsPotential research participantsGroups of parentsFinancial interestsHeart failureHealthy childrenChronic illnessBrain tumorsHealthy adultsClinical researchConsent processAdultsGroup sessionsFocus group sessionsFocus group discussionsParticipantsFocus groupsGroupChildrenResearch participantsEffective disclosureGroup discussionsLeukemiaTumorsIllnessDisclosing Conflicts of Interest in Clinical Research: Views of Institutional Review Boards, Conflict of Interest Committees, and Investigators
Weinfurt KP, Friedman JY, Dinan MA, Allsbrook JS, Hall MA, Dhillon JK, Sugarman J. Disclosing Conflicts of Interest in Clinical Research: Views of Institutional Review Boards, Conflict of Interest Committees, and Investigators. The Journal Of Law, Medicine & Ethics 2006, 34: 581-591. PMID: 17144182, PMCID: PMC1850937, DOI: 10.1111/j.1748-720x.2006.00072.x.Peer-Reviewed Original ResearchMeSH KeywordsAttitude of Health PersonnelBiomedical ResearchCommunication BarriersConflict of InterestDecision MakingDisclosureEthics Committees, ResearchHuman ExperimentationHumansInformed ConsentInterviews as TopicLiability, LegalOrganizational PolicyResearch SubjectsResearch Support as TopicTrustUnited StatesConceptsFinancial interestsConflicts of interestPotential research participantsInstitutional review board chairsInvestigators' financial interestsInterests of participantsResearch participantsBenefits of disclosureLegal liabilityInterest CommitteeResearch institutionsDisclosureConsent processConflictBoard chairsGeneral agreementInstitutionsDecisionsInterestLiabilityRightsGeneral attitudesRationaleReview boardCircumstances